{
  "docId": "019de076-f846-767d-9b7f-8682a04c3e89",
  "docSlug": "d28195e1bb64bc51ad898953c5c30263",
  "documentTitle": "Boundless Bio | IPO Presentation Deck | 51 slides",
  "authorId": "boundless-bio",
  "authorName": "Boundless Bio",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 43,
  "pageCount": 51,
  "prevPage": 42,
  "nextPage": 44,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a 'STARMAP' acronym to describe the study design.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-f846-767d-9b7f-8682a04c3e89/43",
  "deckHref": "/decks/019de076-f846-767d-9b7f-8682a04c3e89",
  "deckJsonHref": "/decks/019de076-f846-767d-9b7f-8682a04c3e89.json",
  "deckAnchorHref": "/decks/019de076-f846-767d-9b7f-8682a04c3e89#slide-43",
  "components": [
    {
      "bbox": {
        "h": 0.72,
        "w": 0.92,
        "x": 0.04,
        "y": 0.17
      },
      "kind": "diagram",
      "text": "Part 1, Part 2, Part 3 clinical trial flow",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5a6a41a4-0bba-4929-8e10-2017659d2b3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.92,
        "x": 0.04,
        "y": 0.94
      },
      "kind": "disclaimer",
      "text": "CRC: Colorectal cancer; MAPK: Mitogen-activated protein kinases; MTD: Maximum Tolerated Dose; RP2D: Recommended Phase 2 Dose; RTK: Receptor tyrosine kinase",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3435ddf3-a2a6-4f26-b241-eb79c8602e3b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.44,
        "x": 0.28,
        "y": 0.9
      },
      "kind": "source-note",
      "text": "\"STARMAP\": Study Treating Acquired Resistance; MAPK Amplifications",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2918e1aa-94e0-48b1-9d0b-fa67cf04aab7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.07
      },
      "kind": "title",
      "text": "Phase 1/2 study of BBI-825 will evaluate prevention and treatment of amplification-mediated resistance to RTK/MAPK pathway inhibitors",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "168537d0-42fe-4c7f-8b3e-e5e3fc73693e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "3bc10a12-fe2c-47de-af07-ec4bb6eb6164",
      "evidence": "Clinical trial design flow",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}